A comprehensive predictive model for radiation-induced brain injury in risk stratification and personalized radiotherapy of nasopharyngeal carcinoma
Yong-Qiao He,Tong-Min Wang,Da-Wei Yang,Wen-Qiong Xue,Chang-Mi Deng,Dan-Hua Li,Wen-Li Zhang,Ying Liao,Ruo-Wen Xiao,Lu-Ting Luo,Hua Diao,Xia-Ting Tong,Yan-Xia Wu,Xue-Yin Chen,Jiang-Bo Zhang,Ting Zhou,Xi-Zhao Li,Pei-Fen Zhang,Xiao-Hui Zheng,Shao-Dan Zhang,Ye-Zhu Hu,Guan-Qun Zhou,Jun Ma,Ying Sun,Wei-Hua Jia
DOI: https://doi.org/10.1016/j.radonc.2023.109974
IF: 6.901
2023-11-02
Radiotherapy and Oncology
Abstract:Background and purpose Radiation-induced brain injury (RBI) is a severe radiotoxicity for nasopharyngeal carcinoma (NPC) patients, greatly affecting their long-term life quality and survival. We aim to establish a comprehensive predictive model including clinical factors and newly developed genetic variants to improve the precision of RBI risk stratification. Materials and methods By performing a large registry-based retrospective study with magnetic resonance imaging follow-up on RBI development, we conducted a genome-wide association study and developed a polygenic risk score (PRS) for RBI in 1189 NPC patients who underwent intensity-modulated radiotherapy. We proposed a tolerance dose scheme for temporal lobe radiation based on the risk predicted by PRS. Additionally, we established a nomogram by combining PRS and clinical factors for RBI risk prediction. Results The 38-SNP PRS could effectively identify high-risk individuals of RBI ( P =1.42×10 -34 ). Based on genetic risk calculation, the recommended tolerance doses of temporal lobes should be 57.6 Gy for individuals in the top 10% PRS subgroup and 68.1 Gy for individuals in the bottom 50% PRS. Notably, individuals with high genetic risk (PRS>P 50 ) and receiving high radiation dose in the temporal lobes (D 0.5CC >65 Gy) had an approximate 50-fold risk over individuals with low PRS and receiving low radiation dose (HR=50.09, 95%CI=24.27-103.35), showing an additive joint effect ( P interaction <0.001). By combining PRS with clinical factors including age, tumor stage, and radiation dose of temporal lobes, the predictive accuracy was significantly improved with C-index increased from 0.78 to 0.85 ( P =1.63×10 -2 ). Conclusions The PRS, together with clinical factors, could improve RBI risk stratification and implies personalized radiotherapy.
oncology,radiology, nuclear medicine & medical imaging